EMILY TODD: Open Payments
NPI 1447813837 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$846 in 48 payments from 10 companies in 2025. Trend: 2023 $1,145 · 2024 $1,273 · 2025 $846
Food & beverage: $846
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $323 |
| GENZYME CORPORATION | 13 | $185 |
| UCB, Inc. | 4 | $94 |
| PFIZER INC. | 3 | $52 |
| Galderma Laboratories, L.P. | 2 | $49 |
| Amgen Inc. | 2 | $38 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $33 |
| Janssen Biotech, Inc. | 2 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| LEO Pharma Inc. | 1 | $16 |
Products named: RINVOQ, DUPIXENT, Bimzelx, SKYRIZI, NEMLUVIO, OTEZLA, CIBINQO, TREMFYA.
Industry payments across NC — which companies pay providers there.
